Trutino Biosciences
Trutino Biosciences (Truitino) designs and manufactures (Cytokine) proteins that makes current cancer treatments more effective and less toxic by activating the patient’s own immune system specifically at the tumor site. Proof-of-concept data demonstrates the method is safe and effective in mice because the molecules are inactive until they reach the tumour, where they become activated and stimulate the patient’s immune system to fight the cancer. The company’s product may also enable existing therapies to treat previously untreatable tumours.